RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance
David T. Miyamoto(Broad Institute), Daniel A. Haber(Howard Hughes Medical Institute), David T. Ting(Massachusetts General Hospital), Douglas B. Fox(Duke University), Ravi Kapur(Harvard University), Richard J. Lee(La Roche College), Katherine Broderick(Harvard University), Kshitij S. Arora(Harvard University), Chin‐Lee Wu, Niyati Desai(Jet Propulsion Laboratory), Brian W. Brannigan(Harvard University), Ben S. Wittner(Broad Institute), Shyamala Maheswaran(Massachusetts General Hospital), Lecia V. Sequist(Harvard University), Julie Trautwein(Harvard University), Mehmet Toner(Shriners Hospitals for Children - Erie), Yu Zheng(Howard Hughes Medical Institute), Matthew R. Smith(Harvard University), Huili Zhu(Yantai University), Rushil Desai(Harvard University), Toshi Shioda(Center for Cancer Research), Sridhar Ramaswamy(Harvard University), Douglas M. Dahl(Harvard University)
Cited by 718
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
|Cell|2004|3.8k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
|New England Journal of Medicine|2010|3.5k